Researcher
Griet Van Lancker
- Disciplines:Palliative care and end-of-life care, Laboratory medicine, Education curriculum, Other translational sciences, Regenerative medicine, Nursing, Other clinical sciences, Other basic sciences, Other paramedical sciences, Other health sciences, Other medical and health sciences
Affiliations
- Department of Basic and Applied Medical Sciences (Department)
Member
From1 Oct 2018 → Today - Department of Pharmacology (Department)
Member
From1 May 2010 → 30 Sep 2018 - Department of Pediatrics and medical genetics (Department)
Member
From1 Jan 2008 → 2 Mar 2008
Publications
1 - 6 of 6
- Single ascending doses of REGN7999, a monoclonal antibody inhibitor of TMPRSS6, increase serum hepcidin and cause deep, sustained reductions in serum iron in healthy human volunteers(2023)Volume: 142
Authors: Sylvie Rottey, Nikhil Singh, Emily Labriola-Tompkins, Heinrich E Lob, Kusha Mohammadi, Hazem Hassan, Lorna Farrelly, Swati Duggal, Harvey Chin, Sarah Hatsell, et al.
Pages: 3841 - 3841 - First-in-human, phase Ia/b, dose-escalation/expansion study of KRAS G12C inhibitor BI 1823911, as monotherapy and combined with anticancer therapies, in patients (pts) with advanced or metastatic solid tumours harbouring a KRAS G12C mutation(2023)Volume: 34
Authors: J. Heymach, N. Kotecki, H. Prenen, G. Alonso, C.R. Lindsay, M. Barve, C. Thamer, S. Eigenbrod-Giese, M.A. Marotti, Griet Van Lancker
Pages: S468 - S468 - A phase 1B multi-tumor cohort study of cabozantinib plus atezolizumab in advanced solid tumors : results of the triple-negative breast cancer, ovarian cancer, and endometrial cancer cohorts(2021)Volume: 9
Authors: Ira Winer, Akhila Wimalasingham, Joaquina Baranda, Armando Santoro, Kristen Spencer, Capucine Baldini, Linda Duska, Vivek Subbiah, Sandip Patel, Polina Khrizman, et al.
Pages: A562 - A562 - Phase I dose escalation study of MCLA-145, a bispecific antibody targeting CD137 and PD-L1 in solid tumors(2021)Volume: 32
Authors: H. Prenen, C. Kyi, Griet Van Lancker, S.P. Patel, D. Mittag, A. Weaver, K. Bol, V. Stalbovskaya, J. Pulini, G. Zhou, et al.
Pages: S1436 - S1436 - Doravirine and the potential for CYP3A-mediated drug-drug interactions(2019)
Authors: SG Khalilieh, KL Yee, RI Sanchez, L Fan, MS Anderson, M Sura, T Laethem, S Rasmussen, Lucas Van Bortel, Griet Van Lancker, et al.
- Pharmacokinetics (PK) and Pharmacodynamics (PD) of a new direct thrombin inhibitor (DPOC-4088) after single oral doses of two prolonged release formulations in healthy male subjects(2011)
Authors: Lucas Van Bortel, Griet Van Lancker, HENRI VANDEN BAVIERE, Willem Hettema, Edwin Spaans, Sankar Ramakrishnan, Venkatesan Elumalai, Suryakumar Jayanthi, Stephane E Allard
Number of pages: 1